SCHEDULE: RA Capital Discloses 11.8% Stake in Septerna, Inc.

RA Capital Management, L.P. and affiliated entities have amended their Schedule 13D filing to report a combined beneficial ownership of 11.8% of Septerna, Inc.'s common stock.

Summary

• RA Capital Management, L.P. and its affiliates (collectively, the 'Reporting Persons') have filed an amendment to their Schedule 13D, reporting a beneficial ownership of 5,525,324 shares of Septerna, Inc. common stock, representing 11.8% of the outstanding shares.
• This ownership includes shares held directly by RA Capital Healthcare Fund, L.P. (4,777,415 shares, 10.2%) and RA Capital Nexus Fund III, L.P. (725,443 shares), as well as vested stock options held by Dr. Simson for the benefit of RA Capital (22,466 shares).
• The filing indicates that RA Capital serves as the investment adviser for the Fund and Nexus Fund III, and has been delegated sole voting and disposition power over the securities held by these entities.
• The Reporting Persons have not engaged in any transactions with respect to Septerna's securities in the past sixty days, except for a block sale of 746,500 shares by the Fund and 746,500 shares by Nexus Fund III on August 12, 2026, at $42.50 per share.
• The filing is an amendment to a previous filing made on November 4, 2024.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this filing as neutral to slightly positive, reflecting a significant ownership stake and active management by RA Capital, but without immediate new strategic initiatives or financial performance data.

Positives

• RA Capital, a significant investment firm, has disclosed a substantial ownership stake of 11.8% in Septerna, Inc., indicating strong conviction in the company's potential.
• The delegation of sole voting and disposition power to RA Capital by its affiliated funds suggests a consolidated and strategic approach to managing this investment.
• The filing is an amendment, implying ongoing engagement and monitoring of the investment by RA Capital.

Negatives

• The filing discloses a block sale of a significant number of shares (1,493,000 total) by RA Capital's affiliated funds on August 12, 2026, at $42.50 per share, which could indicate a reduction in their overall stake or a strategic reallocation.
• No new financial performance data or strategic updates for Septerna, Inc. are provided in this filing, as it primarily concerns ownership disclosure.

Risks

• The block sale on August 12, 2026, at $42.50 per share could signal a potential downward pressure on the stock price if the market interprets it as a lack of confidence or a need for liquidity by RA Capital.
• While not explicitly stated as a risk in this filing, significant ownership by an activist investor like RA Capital can sometimes lead to strategic disagreements with management, potentially creating uncertainty.

Future Outlook

This filing does not contain specific forward-looking statements or guidance from Septerna, Inc. It primarily details the ownership structure and recent transactions of RA Capital Management and its affiliates.

Management Comments

• RA Capital serves as investment adviser for each of the Fund and the Nexus Fund III and may be deemed a beneficial owner, for purposes of Section 13(d) of the Act, of any securities of the Issuer held by the Fund or the Nexus Fund III.
• Each of the Fund and the Nexus Fund III has delegated to RA Capital the sole power to vote and the sole power to dispose of all securities held in its portfolio, including the shares of the Issuer's common stock reported herein.
• Because each of the Fund and the Nexus Fund III has divested itself of voting and investment power over the reported securities it holds and may not revoke that delegation on less than 61 days' notice, each of the Fund and the Nexus Fund III disclaims beneficial ownership of the securities it holds for purposes of Section 13(d) of the Act and therefore disclaims any obligation to report ownership of the reported securities under Section 13(d) of the Act.
• As managers of RA Capital, Dr. Kolchinsky and Mr. Shah may be deemed beneficial owners, for purposes of Section 13(d) of the Act, of any securities of the Issuer beneficially owned by RA Capital.
• RA Capital, Dr. Kolchinsky, and Mr. Shah disclaim beneficial ownership of the securities reported in this Schedule 13D other than for the purpose of determining their obligations under Section 13(d) of the Act, and the filing of this Schedule 13D shall not be deemed an admission that either RA Capital, Dr. Kolchinsky, or Mr. Shah is the beneficial owner of such securities for any other purpose.

Industry Context

StockSavvy.ai notes that Schedule 13D filings are common for institutional investors accumulating significant stakes in public companies. RA Capital is known for its active approach in the biotechnology and healthcare sectors, often taking substantial positions and engaging with management.

Stakeholder Impact

• Shareholders: The significant stake held by RA Capital may influence corporate strategy and governance. The recent block sale could impact short-term stock price volatility.
• Management: RA Capital's substantial ownership and active investment approach may lead to increased engagement with Septerna's management regarding strategic decisions.
• Creditors: No direct impact is indicated in this filing.

Next Steps

• RA Capital will continue to monitor Septerna, Inc.'s performance and strategic direction.
• Further amendments to the Schedule 13D will be filed if there are material changes in beneficial ownership or intentions.

Key Dates

Recommendation

RA Capital's continued significant ownership and active management role suggest a belief in Septerna's long-term prospects. However, the recent block sale introduces some uncertainty. A 'hold' recommendation is appropriate, pending further clarity on RA Capital's strategic intentions and Septerna's operational performance.

Keywords

Schedule 13D, RA Capital Management, Septerna, Inc., Beneficial Ownership, Stock Options, Investment Adviser, Block Sale